title: Lost miRNA surveillance of Notch, IGFR pathway--road to sarcomagenesis.
abstract: The goal of this study was to compare and analyze differentially expressed miRNA and their targets in human chondrosarcoma JJ012 and chondrocytes C 28 cell lines (control) to elucidate deregulation of major signal transduction pathways involved in sarcomagenesis. Total RNA extraction was followed by analyzing RNA quality and integrity. Exiqon human miRNA panel of 743 unique miRNA assays and Illumina microarray HT-12 platform and quantitative reverse transcriptase–PCR verification of targets were performed. The results from human miRNA Exiqon arrays with biological triplicates indicated 28 significant miRNAs (P value ≤0.01). A total 3,045 target genes were derived from the miRWalk database for these 28 miRNAs with 587 common and 2,458 unique target genes. The results of our analyses of the significantly downregulated and upregulated miRNAs in chondrosarcoma cell line indicated the predominant dysregulation of NOTCH, insulin-like growth factor receptor (IGFR), and downstream rat sarcoma, and Src pathways, compared to control. Among the upregulated targets for upregulated miRNAs were the cluster of cancer testis antigen (CTA) genes, located on X chromosome, and their expression was correlated to IGFR pathway activity. Based on our observations, lost miRNA surveillance of NOTCH and IGFR pathways is involved in and leads to sarcomagenesis. We conclude that upregulation of CTA genes is due to hypomethylation that are controlled by epi-miRNAs. We do not preclude the possibility that the upregulated miRNAs, which target CTA genes located in adjacent regions in chromosome X, are epi-miRNAs that influence target gene expression by directly regulating epigenetic processes. Future endeavors will be directed towards understanding the posttranscriptional modifications that affect miRNA expression in sarcomas.
authors: K
authors: K
authors: Galoian
authors: T
authors: T
authors: Guettouche
authors: B
authors: B
authors: Issac
authors: L
authors: L
authors: Navarro
authors: H T
authors: HT
authors: Temple
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000378:metabolism; D019902:Chondrocytes / Q000378:metabolism; D002813:Chondrosarcoma / Q000235:genetics / Q000378:metabolism; D002874:Chromosome Mapping; D041321:Chromosomes, Human, X; D016000:Cluster Analysis; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D051880:Receptors, Notch / Q000235:genetics* / Q000378:metabolism; D017451:Receptors, Somatomedin / Q000235:genetics* / Q000378:metabolism; D012509:Sarcoma / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D035683:MicroRNAs; D051880:Receptors, Notch; D017451:Receptors, Somatomedin
references: Adv Exp Med Biol. 2013;754:137-48
references: 22956499
references: Trends Endocrinol Metab. 2013 Jul;24(7):361-73
references: 23602813
references: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
references: 14973191
references: Semin Oncol. 2011 Oct;38 Suppl 3:S3-18
references: 22055969
references: Cell. 1993 Dec 3;75(5):843-54
references: 8252621
references: Cancer Res. 1999 Jul 1;59(13):3157-65
references: 10397259
references: Tumour Biol. 2012 Jun;33(3):885-90
references: 22246604
references: Discov Med. 2011 Oct;12(65):307-17
references: 22031668
references: Sarcoma. 2012;2012:626094
references: 22701332
references: Cancer Cell. 2009 Aug 4;16(2):126-36
references: 19647223
references: Curr Pathobiol Rep. 2013 Mar;1(1):43-52
references: 23515489
references: Cancer Lett. 2007 Mar 8;247(1):84-90
references: 16730884
references: J Biol Chem. 1996 Aug 9;271(32):19304-9
references: 8702614
references: Cancer Res. 2007 Feb 15;67(4):1419-23
references: 17308078
references: Hum Mol Genet. 1994 Jul;3(7):1117-21
references: 7981680
references: Oncogene. 1997 Sep;15(11):1309-14
references: 9315099
references: Neuro Oncol. 2011 Feb;13(2):165-75
references: 21177782
references: J Clin Invest. 2008 Jan;118(1):217-28
references: 18079963
references: PLoS One. 2010 Sep 30;5(9):
references: 20927335
references: Int J Mol Med. 2013 Apr;31(4):855-60
references: 23426649
references: Biochem Biophys Res Commun. 2007 May 11;356(3):780-4
references: 17382293
references: J Biomed Inform. 2011 Oct;44(5):839-47
references: 21605702
references: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1608-13
references: 18227514
references: Genome Med. 2011 Aug 31;3(8):56
references: 21888691
references: Proc Natl Acad Sci U S A. 1989 Oct;86(19):7480-4
references: 2798419
references: PLoS One. 2010 Nov 30;5(11):e14157
references: 21152401
references: PLoS One. 2012;7(9):e43239
references: 23028448
references: Dev Biol. 2008 Apr 15;316(2):191-9
references: 18334253
references: Mol Cancer Res. 2009 Apr;7(4):523-35
references: 19372581
references: Oncogene. 2010 Apr 29;29(17):2488-98
references: 20154720
references: Case Rep Oncol Med. 2012;2012:621025
references: 23213584
references: Silence. 2010 Feb 02;1(1):6
references: 20226080
references: Oncogene. 2002 Mar 14;21(12):1890-8
references: 11896622
references: Mol Oncol. 2012 Dec;6(6):567-78
references: 22902148
references: Nat Biotechnol. 2008 Apr;26(4):462-9
references: 18362881
references: Int J Cancer. 2005 Aug 20;116(2):200-6
references: 15800911
references: J Bone Joint Surg Am. 1986 Oct;68(8):1197-205
references: 3021775
references: J Clin Invest. 1994 Jul;94(1):445-8
references: 8040287
references: Am J Physiol Endocrinol Metab. 2011 May;300(5):E909-22
references: 21343540
references: Curr Genomics. 2009 Mar;10(1):35-41
references: 19721809
references: Cancer Res. 2006 Oct 1;66(19):9474-82
references: 17018603
references: Wiley Interdiscip Rev RNA. 2011 Sep-Oct;2(5):748-60
references: 21823233
references: Cell Tissue Res. 2008 Nov;334(2):243-54
references: 18855015
references: Br J Cancer. 2009 Jun 16;100(12):1957-65
references: 19455146
references: Genes Chromosomes Cancer. 1999 Dec;26(4):275-85
references: 10534762
references: J Gastroenterol. 2005 Jul;40(7):716-21
references: 16082588
references: Histol Histopathol. 2012 Feb;27(2):151-6
references: 22207549
references: Oncogene. 2006 Feb 16;25(7):1042-52
references: 16247461
references: Exp Biol Med (Maywood). 2007 Apr;232(4):515-22
references: 17392487
references: Endocrinology. 2003 Nov;144(11):4886-93
references: 12960100
references: Nature. 2008 Apr 17;452(7189):896-9
references: 18368051
references: ISRN Oncol. 2012;2012:909453
references: 22852096
references: Growth Horm IGF Res. 2001 Oct;11(5):289-97
references: 11735247
references: Biofactors. 2009 Jan-Feb;35(1):76-81
references: 19319849
references: Nat Rev Cancer. 2006 Nov;6(11):857-66
references: 17060945